abs205.txt	purpose		stereotactic	body	radiation	therapy	(sbrt)	is	an	emerging	option	forlocalized	prostate	cancer	however	there	are	no	standard	dosimetric	guidelines	and	normal	tissue	tolerances	for	extreme	hypofractionation	not	well	defined	we	analyzed	correlations	with	patient-reported	urinary	bowelquality	of	life	(qol)	on	a	prospective	trial	methods	materials	patients	low-	or	intermediate-risk	cancerfrom	18	institutions	were	enrolled	phase	2	from	2007	to	2012	andtreated	using	robotic	sbrt	38	gy	in	4	fractions	consecutive	days	noandrogen	deprivation	was	used	received	simulation	foley	catheterfor	urethral	delineation	the	clinical	target	volume	(low-riskpatients)	plus	1	cm	proximal	seminal	vesicles	(intermediate-riskpatients)	multiple	measures	urethra	bladder	rectum	wereprospectively	recorded	qol	expanded	index	compositewas	assessed	before	after	treatment	at	protocol-specific	time	points	linearregression	assess	factors	associated	month	years	results	total	259	data	available	98%	96%	84%	baseline	respectively	median	age	was69	prior	transurethral	resection	targetvolume	size	2-year	incontinence	trendtoward	worse	obstruction/irritation	older	multivariableanalysis	doses	either	1-month	or2-year	contrast	maximum	dose	both1-month	bowel	proportion	moderate	bigoverall	problems	(as	by	indexcomposite-26)	significantly	higher	dosegreater	than	versus	less	37	(11%	vs	2%	fisher's	exact	testp	=	008)	conclusions	these	provide	novel	that	contribute	betterunderstanding	patient	adverse	qoleffects
